Evoq Remedies, a company in the Trading & Distributors industry, reported revenue of ₹26 crore and net profit of ₹0.05 crore for the September 2025 quarter.
Evoq Remedies (BSE: EVOQ) closed at ₹1.79 on 20 Nov 2026, down 52.1% over the past year. Its market capitalisation is ₹4 crore.
Incorporated in 2010, EVOQ Remedies Ltd is in the pharmaceutical business.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.